Big news: Rare back-to-back studies @Nature provide evidence a bile acid called LCA mediates the health & age slowing benefits of low-calorie diets, and may be the elusive endogenous SIRT1 activator that resveratrol mimics. Details below 🧵
https://t.co/lsiepgMgkM
The human proteomic revolution proceeds with high-throughput assessment, AI analytics, correlation with health and disease, drug interactions, biomarkers
https://t.co/VsYD6vGxXp
Apparently a Bay Area family hired a nanny off the recommendation of her daughter (who allegedly pretended to be a previous client). Nanny goes on to beat the baby all night, caught on camera, then flees back to China. Hard to watch, as a father, this is the kind of thing I'd bring back the death penalty for.
@DionLimTV
The prominent role of the gut microbiome in modulating response to stress and circadian rhythm
https://t.co/q1yQWz5w7W @Cell_Metabolism open-access, by @jfcryan @gabriel_tofani @UCC and colleagues
Interested in therapeutic strategies for autoimmune diseases? This Review in the July issue proposes a three-step strategy towards achieving long-term remissions, and discusses approved and investigational therapies for each step https://t.co/bfqzRPr7tZ https://t.co/4Fd6AjonjA
Thanks @NIH@UFHealthCancer! This is a big effort with two co-PIs Dr Zheng, Guangrong @UFHealthCancer and Dr. Smalley @MoffittNews@LabSmalley to develop next generation PROTACs targeting NR4A1 for potential translation in treating melanoma or other cancer patients.
Please follow this past event and hopefully we can do more in the future to promote accessibility for education, diagnosis, and care for breast cancer patients. Breast Cancer Working Group gathers for networking event » UF Health Cancer Center https://t.co/VxW0OBMvzC
Please check out our collaborative work related to children Sjögren’s syndrome. The first single cell transcriptomics of patients blood versus aged matched control or other related symptoms. Dr. Kim,Myung-Chul was a postdoc in my lab, now assistant prof! https://t.co/lQBrfAQOK7
UF Health Cancer Center researchers have developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of #cancer. The findings were published in @JExpMed.
Read more: https://t.co/jEMW6Tpn6q